DK1054664T3 - Fremgangsmåde til modulering af makrofagaktivering - Google Patents
Fremgangsmåde til modulering af makrofagaktiveringInfo
- Publication number
- DK1054664T3 DK1054664T3 DK99903869.8T DK99903869T DK1054664T3 DK 1054664 T3 DK1054664 T3 DK 1054664T3 DK 99903869 T DK99903869 T DK 99903869T DK 1054664 T3 DK1054664 T3 DK 1054664T3
- Authority
- DK
- Denmark
- Prior art keywords
- macrophage activation
- modulating macrophage
- modulating
- activation
- macrophage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7429598P | 1998-02-11 | 1998-02-11 | |
| US24839699A | 1999-02-10 | 1999-02-10 | |
| PCT/IB1999/000354 WO1999040909A1 (en) | 1998-02-11 | 1999-02-11 | Method for modulating macrophage activation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1054664T3 true DK1054664T3 (da) | 2012-11-05 |
Family
ID=26755484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99903869.8T DK1054664T3 (da) | 1998-02-11 | 1999-02-11 | Fremgangsmåde til modulering af makrofagaktivering |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1054664B1 (da) |
| JP (1) | JP4574845B2 (da) |
| AU (1) | AU2437899A (da) |
| CA (2) | CA2632106A1 (da) |
| CY (1) | CY1113205T1 (da) |
| DK (1) | DK1054664T3 (da) |
| ES (1) | ES2392391T3 (da) |
| HK (1) | HK1032915A1 (da) |
| IL (1) | IL137751A0 (da) |
| MX (2) | MX2008014823A (da) |
| NZ (2) | NZ550199A (da) |
| PT (1) | PT1054664E (da) |
| WO (1) | WO1999040909A1 (da) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| CA2333203A1 (en) * | 1998-05-15 | 1999-11-25 | Neurochem Inc. | Methods for modulating neuronal cell death |
| US6310073B1 (en) | 1998-07-28 | 2001-10-30 | Queen's University At Kingston | Methods and compositions to treat glycosaminoglycan-associated molecular interactions |
| KR100822525B1 (ko) * | 1999-04-28 | 2008-04-16 | 뉴로겜 인터내셔널 리미티드 | 아밀로이드증 치료용 조성물 및 방법 |
| AU5994900A (en) * | 1999-07-09 | 2001-01-30 | Isis Innovation Limited | Compounds for inhibiting diseases and preparing cells for transplantation |
| KR20080003945A (ko) | 1999-12-23 | 2008-01-08 | 뉴로겜 인터내셔널 리미티드 | 대뇌 아밀로이드 혈관병증을 조절하는 화합물 및 방법 |
| US7105336B2 (en) * | 2002-10-07 | 2006-09-12 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
| CA2511599A1 (en) * | 2002-12-24 | 2004-07-15 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| US7244764B2 (en) | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| US20050142191A1 (en) | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| CA2529269C (en) * | 2003-06-23 | 2012-02-07 | Neurochem (International) Limited | Improved pharmaceutical drug candidates and methods for preparation thereof |
| US7414076B2 (en) | 2003-06-23 | 2008-08-19 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| US7253306B2 (en) | 2003-06-23 | 2007-08-07 | Neurochem (International) Limited | Pharmaceutical drug candidates and methods for preparation thereof |
| EP1836161B1 (en) | 2004-12-22 | 2016-07-20 | BHI Limited Partnership | Methods and compositions for treating amyloid-related diseases |
| TW200716088A (en) * | 2005-04-15 | 2007-05-01 | Neurochem Int Ltd | Formulations and methods for treating amyloidosis |
| ES2453941T5 (es) | 2005-11-30 | 2017-05-31 | Abbvie Inc. | Anticuerpos monoclonales contra la proteína beta amiloide y usos de los mismos |
| BRPI0619249A2 (pt) | 2005-11-30 | 2011-09-20 | Abbott Lab | anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos |
| BRPI0620637A2 (pt) | 2005-12-22 | 2011-11-16 | Neurochem Int Ltd | uso de compostos na preparação de medicamentos para a prevenção ou o tratamento de nefropatia diabética, complicação de desordem renal e dislipidemia, redução dos nìveis de lipìdeos e ácido úrico no soro, e aumento do clearance de creatinina e da função renal |
| WO2009019534A2 (en) | 2006-10-12 | 2009-02-12 | Bellus Health (International) Limited | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| WO2008104386A2 (en) | 2007-02-27 | 2008-09-04 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
| US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
| US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
| US9403902B2 (en) | 2007-10-05 | 2016-08-02 | Ac Immune S.A. | Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody |
| WO2010094734A2 (en) * | 2009-02-19 | 2010-08-26 | Biofocus Dpi B.V. | Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
| JP2013505264A (ja) * | 2009-09-17 | 2013-02-14 | ノース テキサス メディカル アソシエイツ | 疼痛制御及び脱髄損傷の回復におけるｎ−２−ヒドロキシ−エチル−ピペラジン−ｎ’−２−エタンスルホン酸（ｈｅｐｅｓ）の役割 |
| EP2558494B1 (en) | 2010-04-15 | 2018-05-23 | AbbVie Inc. | Amyloid-beta binding proteins |
| NZ606357A (en) | 2010-07-30 | 2015-05-29 | Genentech Inc | Safe and functional humanized anti beta-amyloid antibody |
| EP3533803B1 (en) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
| WO2016163886A2 (en) * | 2015-04-10 | 2016-10-13 | Clues2Cure International B.V. | Administration of taurine or an analog thereof for the treatment of nerve cell damage |
| CN109381452A (zh) * | 2017-08-11 | 2019-02-26 | 江西青峰药业有限公司 | 乙基硫酸类化合物的应用及其制备方法 |
| CN109381453A (zh) * | 2017-08-14 | 2019-02-26 | 江西青峰药业有限公司 | 乙基硫酸钾在制备用于预防或治疗炎症性疾病药物中的应用 |
| CN109394746A (zh) * | 2017-08-15 | 2019-03-01 | 江西青峰药业有限公司 | 乙基硫酸铵在制备用于预防或治疗炎症性疾病药物中的应用 |
| WO2023212289A1 (en) | 2022-04-28 | 2023-11-02 | Alzheon, Inc. | Tramiprosate for treating apoe4-related diseases |
| WO2024119183A1 (en) | 2022-12-02 | 2024-06-06 | Alzheon, Inc. | Methods for treating neurodegenerative disorders with tramiprosate |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1144937A (en) * | 1977-12-22 | 1983-04-19 | Dke J.E. Helgstrand | Aromatic derivatives, pharmaceutical compositions and methods for combatting virus infections |
| US5087618A (en) * | 1982-05-18 | 1992-02-11 | University Of Florida | Redox carriers for brain-specific drug delivery |
| US5463092A (en) * | 1989-11-22 | 1995-10-31 | Vestar, Inc. | Lipid derivatives of phosphonacids for liposomal incorporation and method of use |
| US5276059A (en) * | 1992-07-10 | 1994-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of diseases associated with amyloid formation |
| CA2159326C (en) * | 1993-03-29 | 2000-05-30 | Robert Kisilevsky | Method for treating amyloidosis |
| US5643562A (en) * | 1993-03-29 | 1997-07-01 | Queen's University Of Kingston | Method for treating amyloidosis |
| US5840294A (en) * | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| IL134619A0 (en) * | 1997-08-18 | 2001-04-30 | Univ Kingston | Phosphono-carboxylate compounds for treating amyloidosis |
| US5869469A (en) * | 1997-08-18 | 1999-02-09 | Queen's University At Kingston | Phosphonocarboxylate compounds for treating amyloidosis |
-
1999
- 1999-02-11 DK DK99903869.8T patent/DK1054664T3/da active
- 1999-02-11 EP EP99903869A patent/EP1054664B1/en not_active Expired - Lifetime
- 1999-02-11 ES ES99903869T patent/ES2392391T3/es not_active Expired - Lifetime
- 1999-02-11 CA CA002632106A patent/CA2632106A1/en not_active Abandoned
- 1999-02-11 AU AU24378/99A patent/AU2437899A/en not_active Abandoned
- 1999-02-11 CA CA002320224A patent/CA2320224C/en not_active Expired - Lifetime
- 1999-02-11 PT PT99903869T patent/PT1054664E/pt unknown
- 1999-02-11 IL IL13775199A patent/IL137751A0/xx not_active IP Right Cessation
- 1999-02-11 NZ NZ550199A patent/NZ550199A/en not_active IP Right Cessation
- 1999-02-11 WO PCT/IB1999/000354 patent/WO1999040909A1/en active Application Filing
- 1999-02-11 MX MX2008014823A patent/MX2008014823A/es active IP Right Grant
- 1999-02-11 JP JP2000531161A patent/JP4574845B2/ja not_active Expired - Lifetime
- 1999-02-11 NZ NZ568553A patent/NZ568553A/en unknown
- 1999-02-11 MX MXPA00007815A patent/MXPA00007815A/es active IP Right Grant
-
2001
- 2001-05-24 HK HK01103601.4A patent/HK1032915A1/xx not_active IP Right Cessation
-
2012
- 2012-10-16 CY CY20121100954T patent/CY1113205T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1032915A1 (en) | 2001-08-10 |
| PT1054664E (pt) | 2012-11-02 |
| CA2320224A1 (en) | 1999-08-19 |
| AU2437899A (en) | 1999-08-30 |
| WO1999040909A1 (en) | 1999-08-19 |
| JP4574845B2 (ja) | 2010-11-04 |
| IL137751A0 (en) | 2001-10-31 |
| EP1054664B1 (en) | 2012-08-08 |
| CA2632106A1 (en) | 1999-08-19 |
| NZ550199A (en) | 2008-07-31 |
| CA2320224C (en) | 2008-08-12 |
| MXPA00007815A (es) | 2002-04-24 |
| JP2002502871A (ja) | 2002-01-29 |
| CY1113205T1 (el) | 2016-04-13 |
| MX2008014823A (es) | 2009-03-06 |
| EP1054664A1 (en) | 2000-11-29 |
| NZ568553A (en) | 2010-02-26 |
| ES2392391T3 (es) | 2012-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1054664T3 (da) | Fremgangsmåde til modulering af makrofagaktivering | |
| DE69925400D1 (de) | Lasersystem-Steuerung | |
| DE69819044D1 (de) | Vervielfacher für laserwiederholfrequenz | |
| DE69719886D1 (de) | Orthogonales Modulationsverfahren | |
| DK0885968T3 (da) | Fremgangsmåde til fremstilling af vanillin | |
| DE19983678T1 (de) | Bohrloch-Aktivierungssystem | |
| ID27002A (id) | Penghambat-penghambat kaspase | |
| DK1080348T3 (da) | Fremgangsmåde til detektering af farver | |
| DE69830295D1 (de) | Steuerungsverfahren | |
| NO20003581D0 (no) | Kontrollinnretning for sveiseapparat | |
| DE59910525D1 (de) | Operationssystem | |
| DE69906861D1 (de) | Steuermethode | |
| DE69815975D1 (de) | Steuerungsverfahren | |
| DE59811001D1 (de) | Dichtungseinrichtung | |
| DE69932668D1 (de) | Lasersystem | |
| DE69937857D1 (de) | Lasersystem | |
| FI980735A (fi) | Viiveenhallintamenetelmä | |
| NO20006531D0 (no) | Kontrollmetode | |
| ID27022A (id) | Penghambat-penghambat fkbp | |
| DE69937136D1 (de) | Lackiervorrichtung | |
| DE69816734D1 (de) | Steuerungsverfahren | |
| DE69811630D1 (de) | Gummiervorrichtung | |
| DE69906234D1 (de) | Gummiervorrichtung | |
| DK0981950T3 (da) | Fremgangsm,åde til formering af phyllocactus | |
| DE69903035D1 (de) | Erwärmungsverfahren |